These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
312 related items for PubMed ID: 29785888
1. The impact of OPRM1's genetic polymorphisms on methadone maintenance treatment in opioid addicts: a systematic review. Oueslati B, Moula O, Ghachem R. Pharmacogenomics; 2018 Jun 01; 19(8):741-747. PubMed ID: 29785888 [Abstract] [Full Text] [Related]
2. Association between rs1799971 in the mu opioid receptor gene and methadone maintenance treatment response. Xie X, Gu J, Zhuang D, Zhou Y, Chen X, Shen W, Li L, Liu Y, Xu W, Hong Q, Xu Z, Chen W, Zhou W, Liu H. J Clin Lab Anal; 2022 Nov 01; 36(11):e24750. PubMed ID: 36305091 [Abstract] [Full Text] [Related]
3. Response to methadone maintenance treatment is associated with the MYOCD and GRM6 genes. Fonseca F, Gratacòs M, Escaramís G, De Cid R, Martín-Santos R, Fernández-Espejo E, Estivill X, Torrens M. Mol Diagn Ther; 2010 Jun 01; 14(3):171-8. PubMed ID: 20560679 [Abstract] [Full Text] [Related]
4. Genetic polymorphisms in the opioid receptor mu1 gene are associated with changes in libido and insomnia in methadone maintenance patients. Wang SC, Tsou HH, Chen CH, Chen YT, Ho IK, Hsiao CF, Chou SY, Lin YF, Fang KC, Huang CL, Su LW, Fang YC, Liu ML, Wu HY, Lin KM, Liu SC, Kuo HW, Chiang IC, Chen AC, Tian JN, Liu YL. Eur Neuropsychopharmacol; 2012 Oct 01; 22(10):695-703. PubMed ID: 22406240 [Abstract] [Full Text] [Related]
5. OPRM1 genetic polymorphisms are associated with the plasma nicotine metabolite cotinine concentration in methadone maintenance patients: a cross sectional study. Chen YT, Tsou HH, Kuo HW, Fang CP, Wang SC, Ho IK, Chang YS, Chen CH, Hsiao CF, Wu HY, Lin KM, Chen ACh, Tsai-Wu JJ, Liu YL. J Hum Genet; 2013 Feb 01; 58(2):84-90. PubMed ID: 23223006 [Abstract] [Full Text] [Related]
6. [A pharmacogenetic analysis of dopaminergic and opioidergic genes in opioid addicts treated with the combination of naltrexone and guanfacine]. Kibitov АО, Krupitsky ЕМ, Blokhina ЕА, Verbitskaya ЕV, Brodyansky VМ, Alekseeva NP, Bushara NМ, Yaroslavtseva ТS, Palatkin VY, Masalov DV, Burakov АМ, Romanova ТN, Sulimov GY, Grinenko AY, Kosten Т, Nielsen D, Zvartau EE. Zh Nevrol Psikhiatr Im S S Korsakova; 2016 Feb 01; 116(11. Vyp. 2):36-48. PubMed ID: 28300812 [Abstract] [Full Text] [Related]
7. Medication-assisted treatment with methadone: assessing the evidence. Fullerton CA, Kim M, Thomas CP, Lyman DR, Montejano LB, Dougherty RH, Daniels AS, Ghose SS, Delphin-Rittmon ME. Psychiatr Serv; 2014 Feb 01; 65(2):146-57. PubMed ID: 24248468 [Abstract] [Full Text] [Related]
9. κ Opioid Receptor 1 Single Nucleotide Polymorphisms were Associated with the Methadone Dosage. Zhang Q, Shi M, Tang H, Zhong H, Lu X. Genet Test Mol Biomarkers; 2020 Jan 01; 24(1):17-23. PubMed ID: 31940240 [Abstract] [Full Text] [Related]
10. Haplotype-Based Association and In Silico Studies of OPRM1 Gene Variants with Susceptibility to Opioid Dependence Among Addicted Iranians Undergoing Methadone Treatment. Tolami HF, Sharafshah A, Tolami LF, Keshavarz P. J Mol Neurosci; 2020 Apr 01; 70(4):504-513. PubMed ID: 31853823 [Abstract] [Full Text] [Related]
12. The impact of genetic variation on sensitivity to opioid analgesics in patients with postoperative pain: a systematic review and meta-analysis. Ren ZY, Xu XQ, Bao YP, He J, Shi L, Deng JH, Gao XJ, Tang HL, Wang YM, Lu L. Pain Physician; 2015 Apr 01; 18(2):131-52. PubMed ID: 25794200 [Abstract] [Full Text] [Related]
13. Relationship between CYP2B6*6 and cold pressor pain sensitivity in opioid dependent patients on methadone maintenance therapy (MMT). Zahari Z, Lee CS, Ibrahim MA, Musa N, Mohd Yasin MA, Lee YY, Tan SC, Mohamad N, Ismail R. Drug Alcohol Depend; 2016 Aug 01; 165():143-50. PubMed ID: 27289271 [Abstract] [Full Text] [Related]
14. Genome-wide association study of therapeutic opioid dosing identifies a novel locus upstream of OPRM1. Smith AH, Jensen KP, Li J, Nunez Y, Farrer LA, Hakonarson H, Cook-Sather SD, Kranzler HR, Gelernter J. Mol Psychiatry; 2017 Mar 01; 22(3):346-352. PubMed ID: 28115739 [Abstract] [Full Text] [Related]
15. CYP2B6 and OPRM1 Receptor Polymorphisms at Methadone Clinics And Novel OPRM1 Haplotypes: A Cross-Sectional Study. AlMeman AA, Ismail R, Perola M. Drug Metab Lett; 2016 Mar 01; 10(3):213-218. PubMed ID: 27515451 [Abstract] [Full Text] [Related]
16. BDNF variability in opioid addicts and response to methadone treatment: preliminary findings. de Cid R, Fonseca F, Gratacòs M, Gutierrez F, Martín-Santos R, Estivill X, Torrens M. Genes Brain Behav; 2008 Jul 01; 7(5):515-22. PubMed ID: 18182069 [Abstract] [Full Text] [Related]
17. The role of the Chinese police in methadone maintenance therapy: a literature review. Meng J, Burris S. Int J Drug Policy; 2013 Nov 01; 24(6):e25-34. PubMed ID: 23623719 [Abstract] [Full Text] [Related]
18. Clinical use of methadone. Layson-Wolf C, Goode JV, Small RE. J Pain Palliat Care Pharmacother; 2002 Nov 01; 16(1):29-59. PubMed ID: 14650449 [Abstract] [Full Text] [Related]
19. The μ-opioid receptor nonsynonymous variant 118A>G is associated with prolonged abstinence from heroin without agonist treatment. Levran O, Peles E, Randesi M, da Rosa JC, Adelson M, Kreek MJ. Pharmacogenomics; 2017 Oct 01; 18(15):1387-1391. PubMed ID: 28976288 [Abstract] [Full Text] [Related]
20. CYP2B6 SNPs are associated with methadone dose required for effective treatment of opioid addiction. Levran O, Peles E, Hamon S, Randesi M, Adelson M, Kreek MJ. Addict Biol; 2013 Jul 01; 18(4):709-16. PubMed ID: 21790905 [Abstract] [Full Text] [Related] Page: [Next] [New Search]